Patients successfully treated for a common heart rhythm disorder may no longer need blood thinners, a major study has found.

On November 3, 2025, Chief Technical Officer Joseph Shulman of Rhythm Pharmaceuticals ( RYTM +1.84%) exercised 9,748 options ...

"Rhythm forced to wait for Imcivree expansion as FDA delays decision " was originally created and published by Pharmaceutical ...

Rhythm Pharmaceuticals said on Friday the U.S. Food and Drug Administration has extended the review period for expanded ...

Investing.com -- Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) stock fell 3.4% in premarket trading Friday after the company announced the U.S. Food and Drug Administration (FDA) has extended its review ...

Company to hold conference today at 8:00 a.m. -- BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals said on Friday the U.S. Food and Drug Administration has extended the review period for expanded approval of its drug, Imcivree, as a treatment for a rare form of obesity.

Suri: The Seventh Note is an Indian-made rhythm action platformer coming to PS5 and PC. A release date hasn’t been announced ...

A mathematical model reveals circadian rhythms' impact on medication efficacy, particularly for neurological conditions like Parkinson’s disease and depression. The model focuses on dopamine reuptake ...

More than 4 in 5 women are gritting out menopause without seeking any treatment for their symptoms, researchers said in a new ...

People with a condition in which protein build up stiffens heart walls – called transthyretin amyloid cardiomyopathy – were more likely to have a stroke if they also had a mechanical malfunction in ...

The truth became unavoidable: the traditional school setting was never going to be able to meet our daughter's needs.